
Research published in Cancer Research suggests sildenafil, the active ingredient in Viagra, may block cancer cells from accessing cholesterol needed to spread to other organs.
A study of five million medical records, including 40,000 cancer patients, found that men who used sildenafil had better overall survival rates than those who did not.
Experts emphasize that these findings are early-stage and do not constitute a cancer treatment, advising patients against using the drug for this purpose without medical consultation.